HighTower Advisors’s Enlivex Therapeutics ENLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-600
Closed -$17K 2136
2017
Q2
$17K Hold
600
﹤0.01% 2050
2017
Q1
$19K Hold
600
﹤0.01% 1948
2016
Q4
$26K Sell
600
-238
-28% -$10.3K ﹤0.01% 1841
2016
Q3
$59K Sell
838
-55
-6% -$3.87K ﹤0.01% 1772
2016
Q2
$57K Hold
893
﹤0.01% 1630
2016
Q1
$86K Hold
893
﹤0.01% 1853
2015
Q4
$140K Hold
893
﹤0.01% 1807
2015
Q3
$182K Sell
893
-7
-0.8% -$1.43K ﹤0.01% 1663
2015
Q2
$248K Buy
+900
New +$248K ﹤0.01% 1276